Clinical Trials

Prostate Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 6 of 6 Clinical Trials Related to Prostate Cancer

Clinical Research Trial

SWOG S2312 Prostate Cancer

A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate Resistant Prostate Cancer (MCRPC), Stratified by Aggressive Variant Signature

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

Amgen 757 Lung Cancer

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306)

Doctor(s) Running This Study
Suresh G. Nair, MD
Nicholas E. Lamparella, DO
M. Bijoy Thomas, MD
Jeffrey T. Brodsky, MD
Brian J. Patson, MD
Maged F. Khalil, MD
Bradley W. Lash, MD
Jeanette M. Blauth, MD
Lori A. Alfonse, DO
Simi Masand Rai, MD
Don J. Park, MD, PHD
Muhammad A. Rizvi, MD
Hasan H. Danish, MD
Heiwon Chung Whang, MD
Eliot L. Friedman, MD
Tara Morrison, MD
Paul Palyca, MD
Alyson F. McIntosh, MD, MPHIL
Aaron U. Blackham, MD
Clinical Research Trial

Alliance A032101

A032101 Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

GU-006

A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or Without Enhanced Anti-Androgen Therapy with Apalutamide in Recurrent Prostate Cancer

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

GU-005

Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer

Doctor(s) Running This Study
Maged F. Khalil, MD